Prognostic Impact of Revascularization in Poor-Risk Patients With Critical Limb Ischemia: The PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia)
- PMID: 28595883
- DOI: 10.1016/j.jcin.2017.03.012
Prognostic Impact of Revascularization in Poor-Risk Patients With Critical Limb Ischemia: The PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia)
Abstract
Objectives: The authors sought to investigate the prognostic impact of revascularization for poor-risk CLI patients in real-world settings.
Background: Critical limb ischemia (CLI) is often accompanied with various comorbidities, and frailty is not rare in the population. Although previous studies suggested favorable outcomes of revascularization for CLI patients, those studies commonly included the healthier, that is, less frail patients.
Methods: This was a multicenter prospective observational study, registering patients who presented with CLI and who required assistance for their daily lives because of their disability in activities of daily living (ADL) and/or impairment of cognitive function. Revascularization was either planned (revascularization group) or not planned (non-revascularization group). The primary endpoint was 1-year survival, and was compared between the revascularization and non-revascularization groups, using the propensity score-matching method.
Results: Between January 2014 and April 2015, a total of 662 patients were registered, of those 100 non-revascularization patients were included. A total of 625 patients (94.4%) completed the 1-year follow-up. Death was observed in 223 patients (33.7%). After propensity score matching, the 1-year survival rate was 55.9% in the revascularization group versus 51.0% in the non-revascularization group, with no significant difference (p = 0.120). In the subgroups alive at 1 year after revascularization, health-related quality of life was significantly improved compared with baseline, whereas ADL scores were unchanged from baseline and still remained significantly worse than before CLI onset.
Conclusions: The 1-year overall survival rate was not significantly different between the revascularization and non-revascularization groups in poor-risk CLI patients. (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia; [PRIORITY Registry]; UMIN000012871).
Keywords: critical limb ischemia; mortality; revascularization.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Chronic Limb Ischemia: Ischemia in the Extreme.JACC Cardiovasc Interv. 2017 Jun 12;10(11):1158-1160. doi: 10.1016/j.jcin.2017.04.017. JACC Cardiovasc Interv. 2017. PMID: 28595884 No abstract available.
Similar articles
-
Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia).Circ Cardiovasc Interv. 2017 Dec;10(12):e005531. doi: 10.1161/CIRCINTERVENTIONS.117.005531. Circ Cardiovasc Interv. 2017. PMID: 29246911 Free PMC article.
-
3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.JACC Cardiovasc Interv. 2015 Sep;8(11):1493-1502. doi: 10.1016/j.jcin.2015.07.005. JACC Cardiovasc Interv. 2015. PMID: 26404203
-
Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia.J Vasc Surg. 2013 Jul;58(1):98-104.e1. doi: 10.1016/j.jvs.2012.12.076. Epub 2013 May 14. J Vasc Surg. 2013. PMID: 23683380
-
Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.J Vasc Surg. 2021 Feb;73(2):711-721.e3. doi: 10.1016/j.jvs.2020.08.125. Epub 2020 Sep 4. J Vasc Surg. 2021. PMID: 32891809 Free PMC article.
-
The Double Burden: Deciphering Chronic Limb-Threatening Ischemia in End-Stage Renal Disease.Ann Vasc Surg. 2024 Oct;107:105-121. doi: 10.1016/j.avsg.2023.12.102. Epub 2024 Apr 9. Ann Vasc Surg. 2024. PMID: 38599491 Review.
Cited by
-
Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia.J Atheroscler Thromb. 2022 Jun 1;29(6):866-880. doi: 10.5551/jat.62892. Epub 2021 May 27. J Atheroscler Thromb. 2022. PMID: 34039832 Free PMC article.
-
Autologous angiogenic therapy with cultured mesenchymal stromal cells in platelet-rich plasma for critical limb ischemia.Regen Ther. 2023 Sep 21;24:472-478. doi: 10.1016/j.reth.2023.09.011. eCollection 2023 Dec. Regen Ther. 2023. PMID: 37772129 Free PMC article.
-
Wound formation in patients with Rutherford category IV disease after endovascular therapy: rates and risk factors.CVIR Endovasc. 2024 Dec 7;7(1):86. doi: 10.1186/s42155-024-00500-3. CVIR Endovasc. 2024. PMID: 39644409 Free PMC article.
-
Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease.Crit Pathw Cardiol. 2018 Jun;17(2):53-68. doi: 10.1097/HPC.0000000000000149. Crit Pathw Cardiol. 2018. PMID: 29768312 Free PMC article. Review. No abstract available.
-
To Treat or not to Treat? The Fate of Patients with Intermittent Claudication Following Different Therapeutic Options.Rev Cardiovasc Med. 2024 Jun 24;25(6):229. doi: 10.31083/j.rcm2506229. eCollection 2024 Jun. Rev Cardiovasc Med. 2024. PMID: 39076305 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous